期刊文献+

流感病毒神经氨酸酶抑制剂筛选模型的建立和应用 被引量:32

ESTABLISHMENT AND APPLICATION OF HIGH THROUGHPUT SCREENING MODEL FOR INFLUENZA VIRUS NEURAMINIDASE INHIBITORS IN VITRO
下载PDF
导出
摘要 目的 建立适用于高通量筛选的流感病毒神经氨酸酶 (neuraminidase ,NA)抑制剂筛选模型。方法 从甲型及乙型流感病毒中制备神经氨酸酶 ,以 2′ (4 methylumbelliferyl) α D N acetylneuraminicacid(MUNANA)作为底物 ,建立检测神经氨酸酶活性的荧光测定法及其抑制剂体外筛选方法 ,用高通量筛选系统对 12 0 0个化合物与提取物进行初筛。结果 神经氨酸酶酶促反应以pH 3 5 ,二价阳离子浓度为 2~ 6mmol·L- 1 及 37℃孵育时酶活性最佳 ;甲、乙型流感病毒不同株神经氨酸酶的米氏常数 (Km)的范围为 (4 89~ 5 94) μmol·L- 1 ;初筛发现 12个化合物对流感病毒神经氨酸酶有可重复的抑制活性。结论 优化了神经氨酸酶反应体系 ,建立的体外模型可用于抗甲、乙型流感病毒药物的高通量筛选及酶抑制动力学的研究。 AIM In order to find novel inhibitors of influenza virus neuraminidase (NA), an assay method of neuraminidase activity was established for high throughput screening. METHODS The strain A (Yuefang 72-243 A and Jifang 90-15 A) and B (Sichuan 2000-38 B) influenza viruses were used as source of neuraminidase and the activity of neuraminidase was measured by fluorometric method. The reaction system of neuraminidase with substrate, 2′-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid (MUNANA) was optimized by changing the conditions such as concentrations of neuraminidase, substrate, Ca 2+, reactive system pH and temperature. At last, the inhibitory effects of 1 200 samples (including compounds and extracts from plants) were screened by the fluorometric assay. RESULTS The optimized neuraminidase reaction system contains enzyme, MUNANA 20 μmol·L -1, Ca 2+ 4 mmol·L -1, at pH 3.5 and 37℃. The Michaelis and Menten constants (Km) of influenza virus A (Yuefang 72-243 and Jifang 90-15) and B (Sichuan 2000-38) are (5.9±1.9), (5.2±0.5) and (4.9±1.2) μmol·L -1 respectively. Among 1 200 samples, there were about 1% showed potential inhibitory effects on influenza virus neuraminidase. CONCLUSION The temperature, pH and concentrations of substrate and ions are very important factors affecting the influenza virus neuraminidase activity in vitro. The fluorometric assay of neuraminidase was performed by automatic laboratory station to screen inhibitors of influenza virus neuraminidase in vitro. It can also be used to study the enzyme inhibition kinetics.
出处 《药学学报》 CAS CSCD 北大核心 2002年第12期930-933,共4页 Acta Pharmaceutica Sinica
基金 国家高技术研究发展计划 ( 86 3)专项经费资助项目( 2 0 0 1AA2 340 21) 国家自然科学基金重点资助项目( 30 0 116 1940 )
  • 相关文献

参考文献8

  • 1Calfee DP, Hayden FG. New approaches to influenza chemotherapy neuraminidase inhibitors [J]. Drugs, 1998,56(4):537-553.
  • 2Gubareva LV, Kaiser L, Hayden FG. Influenza virus neuraminidase inhibitors [J]. Lancet 2000,355(9206):827-835.
  • 3Khare MD, Sharland M. Influenza [J]. Exp Opin Pharmacother, 2000,1(3):367-375.
  • 4Cox NJ, Subbarao K. Influenza [J]. Lancet, 1999,354(9186):1277-1282.
  • 5Kandel R, Hartshorn KL. Prophylaxis and treatment of influenza virus infection [J]. BioDrug 2001,15(5):303-323.
  • 6Cheer SM, Wagstaff AJ. Zanamivir: an update of its use in influenza [J]. Drugs, 2002,62(1):71-106.
  • 7Tai CY, Escarpe PA, Sidwell RW, et al. Characterization of human influenza virus variants selected in vitro in the presence of the neuraminidase inhibitor GS4071 [J]. Antimicrob Agents Chemother, 1998,42(12):3234-3241.
  • 8Potier M, Mameli L, Belisle M, et al. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-α-D-N-acetylneuraminate) substrate [J]. Anal Biochem, 1979,94:287-296.

同被引文献231

引证文献32

二级引证文献298

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部